Evidence map›Paper›PMID 25697699›Full record

ArticleJournal of Alzheimer's disease : JAD2015

Mortality in mild cognitive impairment varies by subtype, sex, and lifestyle factors: the Mayo Clinic Study of Aging.

Maria Vassilaki, Ruth H Cha, Jeremiah A Aakre, Terry M Therneau, Yonas E Geda, Michelle M Mielke, David S Knopman, Ronald C Petersen, Rosebud O Roberts

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Crime, mortality and neurocognitive disorders: A nationwide register study in Finland.International journal of methods in psychiatric research · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Maria VassilakiDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Ruth H ChaDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Jeremiah A Aakre
Terry M Therneau
Yonas E GedaDepartment of Psychiatry and Psychology, Mayo Clinic, Scottsdale, Arizona, USA Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
Michelle M MielkeDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
David S KnopmanDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Rosebud O RobertsDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Mayo Clinic in Florida · USMayo Clinic · USMayo Clinic in Arizona · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI VEMURI, PRASHANTHI · 1999 to 2018
$36.9M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Psychiatric Characterization/Mild Cognitive ImpairmentK01MH068351 · NIMH · MAYO CLINIC ROCHESTER · PI GEDA, YONAS E · 2004 to 2008
$890k
Vascular /Inflammatory Predictors of MCI Risk /ProgressiK01AG028573 · NIA · MAYO CLINIC ROCHESTER · PI ROBERTS, ROSEBUD O · 2006 to 2008
$351k
NCATS NIH HHS UL1 TR000135NIA NIH HHS K01 AG028573NIA NIH HHS P50 AG016574NIA NIH HHS R01 AG034676NIA NIH HHS U01 AG006786NIMH NIH HHS K01 MH068351
6 · The paper itself

Abstract

backgroundEtiologic differences in mild cognitive impairment (MCI) subtypes may impact mortality.

objectiveTo assess the rate of death in MCI overall, and by subtype, in the population-based Mayo Clinic Study of Aging.

methodsParticipants aged 70-89 years at enrollment were clinically evaluated at baseline and 15-month intervals to assess diagnoses of MCI and dementia. Mortality in MCI cases versus cognitively normal (CN) individuals was estimated using Cox proportional hazards models.

resultsOver a median follow-up of 5.8 years, 331 of 862 (38.4%) MCI cases and 224 of 1,292 (17.3%) cognitively normal participants died. Compared to CN individuals, mortality was elevated in persons with MCI (hazard ratio [HR] = 1.79; 95% CI: 1.41 to 2.27), and was higher for non-amnestic MCI (naMCI; HR = 2.40; 95% CI: 1.72 to 3.36) than for amnestic MCI (aMCI; HR = 1.61; 95% CI: 1.25 to 2.09) after adjusting for confounders. Mortality varied significantly by sex, education, history of heart disease, and engaging in moderate physical exercise (p for interaction <0.05 for all). Mortality rate estimates were highest in MCI cases who were men, did not exercise, had heart disease, and had higher education versus CN without these factors, and for naMCI cases versus aMCI cases without these factors.

conclusionsThese findings suggest stronger impact of etiologic factors on naMCI mortality. Prevention of heart disease, exercise vigilance, may reduce MCI mortality and delayed MCI diagnosis in persons with higher education impacts mortality.

Indexed as

AgedAged, 80 and overCognitive DysfunctionEducational StatusExerciseFemaleFollow-Up StudiesHeart DiseasesHumansKaplan-Meier EstimateLife StyleLongitudinal StudiesMaleMinnesotaNeuropsychological TestsProportional Hazards ModelsCohort studiesincidence studiesmild cognitive impairmentmortalityoutcomes researchprognosis

Identifiers

PMID25697699
PMCPMC4398642
OpenAlexW1591206803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.